Predicting hospital readmission risks for diabetes patients
Developing and validating EHR-integrated readmission risk prediction models for hospitalized patients with diabetes
['FUNDING_R01'] · TEMPLE UNIV OF THE COMMONWEALTH · NIH-10850712
This study is working on creating better tools to help doctors predict which diabetes patients might need to go back to the hospital, so they can provide the right support to keep you healthy and avoid unnecessary trips to the hospital.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEMPLE UNIV OF THE COMMONWEALTH (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10850712 on ClinicalTrials.gov |
What this research studies
This research focuses on developing and validating models that predict the risk of hospital readmission for patients with diabetes. It aims to improve the accuracy of existing prediction tools by integrating electronic health records (EHR) data, which will streamline the process and make it more efficient for healthcare providers. By identifying high-risk patients, the research seeks to enable targeted interventions that could prevent unnecessary readmissions. The study builds on previous models and aims to enhance their predictive accuracy while ensuring ease of use in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are hospitalized patients diagnosed with diabetes who are at risk of being readmitted within 30 days of discharge.
Not a fit: Patients without diabetes or those who are not hospitalized may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce hospital readmissions for diabetes patients, leading to better health outcomes and lower healthcare costs.
How similar studies have performed: Previous research has shown promise in using predictive models for readmission risks, indicating that this approach could lead to meaningful advancements in patient care.
Where this research is happening
PHILADELPHIA, UNITED STATES
- TEMPLE UNIV OF THE COMMONWEALTH — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RUBIN, DANIEL J — TEMPLE UNIV OF THE COMMONWEALTH
- Study coordinator: RUBIN, DANIEL J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: diabetes, Diabetes Mellitus